RESEARCH - Cimzia plus MTX improves patient-reported RA outcomes

[Guest guest]

Certolizumab Plus Methotrexate Improves Patient-Reported RA Outcomes

NEW YORK (Reuters Health) Nov 23 - Adding certolizumab pegol to

methotrexate improves health-related quality of life, fatigue, and

other patient-reported outcomes in rheumatoid arthritis (RA),

according to results of a randomized, placebo-controlled trial.

" (Patient-related outcomes) correlate so well with work productivity

data, x-ray, and clinical responses, but most importantly these are

the most robust 'patient centric' data and include productivity within

as well as outside the home and family, social, and leisure

activities, " Dr. Vibeke Strand from Stanford University School of

Medicine, Palo Alto, California, told Reuters Health in an email.

In the open-access online journal Arthritis Research and Therapy, Dr.

Strand and colleagues present the patient-reported outcomes from the

RAPID 1 trial of the pegylated anti-tumor necrosis factor

certolizumab, and they also examine the correlations between patients'

self-reports and their American College of Rheumatology (ACR)20 and

Disease Activity Score (DAS) responses.

**************************************

Read the rest of the article here:

http://www.medscape.com/viewarticle/712927

Not an MD